-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Initiates Coverage On Haemonetics with Buy Rating, Announces Price Target of $150

Benzinga·11/13/2026 13:17:05
Diffusion vocale
Jefferies analyst Young Li initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of $150.